PharmaKnowl Consulting joined healthcare innovators, medical device manufacturers, regulators, and technology providers at the Global Health Exhibition 2025, held from 27–30 October 2025 at the Riyadh Exhibition and Convention Center, Saudi Arabia.
Our team met with organizations exploring opportunities in the Saudi healthcare sector and discussed the evolving regulatory landscape for medical devices, digital health technologies, and in vitro diagnostics. As healthcare innovation accelerates across the Kingdom, many international companies are seeking experienced local partners to help navigate regulatory requirements and achieve successful market entry.
The exhibition reflected Saudi Arabia’s ambition to become a regional hub for healthcare innovation, supporting the healthcare transformation goals of Vision 2030. Bringing together stakeholders from across the public and private sectors, the event showcased emerging technologies, digital transformation initiatives, and next-generation medical solutions that are helping shape the future of healthcare. Conversations throughout the exhibition highlighted the growing importance of regulatory readiness, quality systems, and cross-sector collaboration in enabling the safe and efficient introduction of innovative healthcare products into the Saudi market.
During the exhibition, PharmaKnowl presented its specialized regulatory consulting services for the MedTech sector, including SFDA medical device registration, Authorized Representative services, regulatory strategy, quality management support, and guidance for companies expanding into Saudi Arabia and the wider GCC region. Beyond the exhibition floor, the event provided an opportunity to strengthen relationships with existing partners, establish new industry connections, and gain valuable insights into the priorities shaping the future of healthcare in the region.
Our participation at the Global Health Exhibition 2025 reinforces PharmaKnowl Consulting’s role as a trusted regulatory partner for companies looking to bring innovative healthcare solutions to Saudi Arabia. By staying closely engaged with industry developments and supporting Vision 2030’s objectives, we continue to help our clients navigate regulatory challenges with confidence while contributing to a more innovative, accessible, and sustainable healthcare ecosystem.




About the Author
Contributed by the PharmaKnowl regulatory affairs team, based in Riyadh. Written and reviewed by our SFDA-experienced consultants.
Resources
Services
Events




